Indian Pharmacopoeia 2018: Addendum 2021

Salient Features of Addendum 2021 to IP 2018

Published by: Indian Pharmacopoeia Commission (IPC)
(Ministry of Health and Family Welfare, Government of India)
Sector 23, Raj Nagar, Ghaziabad 201 002, India

Effective Date: 1st October, 2021

Salient Features:

Addendum 2021 contains 66 new monographs including chemical (59), herbs and herbal products (05), & blood and blood related products (02)

Special emphasis has been given to the dosage forms of API whose dosage forms were not in the IP 2018

General chemical tests for identification of an article have been almost eliminated and more specific infrared, ultraviolet spectrophotometric, HPLC and HPTLC tests have been given emphasis

Special emphasis was given to include/upgrade dissolution test in

dosage forms were not in the IP 2018

General chemical tests for identification of an article have been almost eliminated and more specific infrared, ultraviolet spectrophotometric, HPLC and HPTLC tests have been given emphasis

Special emphasis was given to include/upgrade dissolution test in existing monographs

Most of the existing assays and related substances tests have been upgraded to liquid chromatography method

Addendum 2021 to IP 2018: Monograph Additions

New Monographs : 66

Dosage Forms ( Chemical ) : 38

APIs : 21

Herbs and Herbal Products : 5

Blood and Blood Related Products : 2

General Chapters : 4

Addendum 2021 to IP 2018: Addition of New Monographs

Chemical Monographs : 59

Herbs and Herbal Products : 5

Blood and Blood Related Products : 2